GeoVax Labs, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| SPENCER JOHN N JR | — | Purchase | 10,000 | $0.55 | $5,500 | 21,402 | Oct 17, 2025 |
| McKee Kelly T. Jr. | Chief Medical Officer | Purchase | 1,107 | $0.67 | $742 | 3,494 | Aug 7, 2025 |
| SPENCER JOHN N JR | — | Purchase | 10,000 | $0.98 | $9,800 | 11,402 | Apr 10, 2025 |
| Sharkey John W. | VP, Business Development | Purchase | 6,000 | $0.99 | $5,940 | 6,191 | Apr 10, 2025 |
| DODD DAVID A | President, CEO | Purchase | 10,000 | $1.08 | $10,800 | 36,661 | Apr 1, 2025 |
| Reynolds Mark | CFO | Purchase | 6,800 | $1.08 | $7,344 | 14,013 | Mar 31, 2025 |
| DODD DAVID A | President, CEO | Purchase | 8,000 | $1.95 | $15,600 | 26,661 | Aug 9, 2024 |
| DODD DAVID A | President, CEO | Purchase | 520 | $2.15 | $1,118 | 10,452 | Feb 22, 2024 |
| Reynolds Mark | CFO | Purchase | 2,000 | $2.77 | $5,540 | 7,213 | Feb 7, 2024 |
| McKee Kelly T. Jr. | Chief Medical Officer | Purchase | 6,944 | $0.36 | $2,500 | 35,782 | Dec 22, 2023 |
| McKee Kelly T. Jr. | Chief Medical Officer | Purchase | 9,653 | $0.52 | $5,020 | 28,838 | Sep 25, 2023 |
| DODD DAVID A | President, CEO | Purchase | 35,087 | $0.57 | $20,000 | 148,957 | Aug 25, 2023 |
| Reynolds Mark | CFO | Purchase | 10,000 | $0.52 | $5,200 | 78,184 | Aug 18, 2023 |
| DODD DAVID A | President, CEO | Purchase | 32,000 | $0.64 | $20,480 | 113,870 | Apr 24, 2023 |
| Reynolds Mark | CFO | Purchase | 8,000 | $0.63 | $5,040 | 68,184 | Apr 20, 2023 |
| CHASE RANDAL D | — | Purchase | 10,000 | $1.10 | $11,000 | 36,613 | Sep 21, 2022 |
| Sharkey John W. | VP, Business Development | Purchase | 1,000 | $0.82 | $820 | 2,860 | Jul 1, 2022 |
| McKee Kelly T. Jr. | Chief Medical Officer | Purchase | 4,464 | $1.12 | $5,000 | 19,185 | Jun 27, 2022 |
| CHASE RANDAL D | — | Purchase | 10,000 | $1.21 | $12,100 | 26,613 | Jun 21, 2022 |
| McKee Kelly T. Jr. | Chief Medical Officer | Purchase | 9,722 | $0.72 | $7,000 | 14,721 | May 5, 2022 |
| McKee Kelly T. Jr. | Chief Medical Officer | Purchase | 4,999 | $0.71 | $3,549 | 4,999 | May 4, 2022 |
| Reynolds Mark | CFO | Purchase | 60,184 | $5.00 | $300,920 | 60,184 | Sep 29, 2020 |
| DODD DAVID A | President, CEO | Purchase | 81,870 | $5.00 | $409,350 | 81,870 | Sep 29, 2020 |
| MCNALLY ROBERT T | — | Purchase | 53,925 | $5.00 | $269,625 | 53,925 | Sep 29, 2020 |
| SPENCER JOHN N JR | — | Purchase | 21,024 | $5.00 | $105,120 | 21,024 | Sep 29, 2020 |
| Kollintzas Dean G | — | Purchase | 11,987 | $5.00 | $59,935 | 11,987 | Sep 29, 2020 |
| CHASE RANDAL D | — | Purchase | 16,613 | $5.00 | $83,065 | 16,613 | Sep 29, 2020 |
| CHASE RANDAL D | — | Purchase | 200 | $0.19 | $38 | 40,000 | May 5, 2015 |
| Reynolds Mark | CFO | Purchase | 10,000 | $0.17 | $1,700 | 46,000 | Apr 23, 2015 |
| SPENCER JOHN N JR | — | Purchase | 18,000 | $0.17 | $3,060 | 46,625 | Apr 20, 2015 |
| CHASE RANDAL D | — | Purchase | 30,000 | $0.17 | $5,100 | 30,000 | Apr 20, 2015 |
| ROBINSON HARRIET L | Chief Scientific Officer | Gift | 27,500 | — | — | 1,173,726 | Jun 5, 2013 |
| Reynolds Mark | CFO | Purchase | 15,000 | $0.67 | $10,050 | 36,000 | Jan 31, 2012 |
| Antebi Steven S. | — | Purchase | 30,000 | $0.67 | $20,100 | 30,000 | Jan 16, 2012 |
| SPENCER JOHN N JR | — | Purchase | 14,925 | $0.67 | $10,000 | 28,625 | Dec 30, 2011 |
| Kollintzas Dean G | — | Purchase | 14,925 | $0.67 | $10,000 | 14,925 | Dec 30, 2011 |
| DODD DAVID A | — | Purchase | 112,000 | $0.67 | $75,040 | 127,725 | Dec 30, 2011 |
| ROBINSON HARRIET L | Chief Scientific Officer | Purchase | 149,254 | $0.67 | $100,000 | 1,201,226 | Dec 30, 2011 |
| MCNALLY ROBERT T | President/CEO | Purchase | 29,850 | $0.67 | $20,000 | 29,850 | Dec 30, 2011 |
| Reynolds Mark | CFO | Purchase | 15,000 | $0.67 | $10,050 | 21,000 | Dec 30, 2011 |
| ROBINSON HARRIET L | Chief Scientific Officer | Gift | 7,422 | — | — | 1,051,972 | Jun 22, 2011 |
| ROBINSON HARRIET L | Chief Scientific Officer | Gift | 9,714 | — | — | 1,059,394 | Jan 6, 2011 |
| ROBINSON HARRIET L | Chief Scientific Officer | Gift | 33,333 | — | — | 1,069,108 | Dec 20, 2010 |
| MCNALLY ROBERT T | President & CEO | Gift | 8,300 | — | — | — | Oct 15, 2010 |
| Reynolds Mark | Chief Financial Officer | Purchase | 1,000 | $2.50 | $2,500 | 6,000 | Jul 2, 2010 |
| NEWMAN MARK J | VP, Research & Development | Purchase | 2,000 | $3.32 | $6,640 | 3,000 | Jun 11, 2010 |
| ROBINSON HARRIET L | Chief Scientific Officer | Purchase | 2,100 | $3.35 | $7,035 | 1,102,441 | Jun 10, 2010 |
| ROBINSON HARRIET L | Chief Scientific Officer | Purchase | 3,000 | $3.30 | $9,900 | 1,100,341 | Jun 10, 2010 |
| MCNALLY ROBERT T | President & CEO | Purchase | 300 | $3.30 | $990 | 8,300 | Jun 10, 2010 |
| Reynolds Mark | Chief Financial Officer | Purchase | 530 | $3.35 | $1,776 | 5,000 | Jun 9, 2010 |